Evidence map›Paper›PMID 29148972›Full record

ArticleeLife2017

Rapid DNA replication origin licensing protects stem cell pluripotency.

Jacob Peter Matson, Raluca Dumitru, Philip Coryell, Ryan M Baxley, Weili Chen, Kirk Twaroski, Beau R Webber, Jakub Tolar, Anja-Katrin Bielinsky, Jeremy E Purvis and 1 more

Erratum issuedAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Article
  2. Article
  3. CDC7 and APC/CNature communications · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Coupling of stemness maintenance with cell cycle control in stem cells.Frontiers in cell and developmental biology · 2025
    Review
  17. Article
  18. Article
  19. APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jacob Peter MatsonDepartment of Biochemistry and Biophysics, The University of North Carolina, Chapel Hill, United States.ORCID http://orcid.org/0000-0002-9375-1676
Raluca DumitruHuman Pluripotent Stem Cell Core Facility, The University of North Carolina, Chapel Hill, United States.
Philip CoryellDepartment of Genetics, The University of North Carolina, Chapel Hill, United States.
Ryan M BaxleyDepartment of Biochemistry, Molecular Biology, and Biophysics, The University of Minnesota, Minneapolis, United States.
Weili ChenStem Cell Institute, University of Minnesota, Minnesota, United States.
Kirk TwaroskiStem Cell Institute, University of Minnesota, Minnesota, United States.
Beau R WebberStem Cell Institute, University of Minnesota, Minnesota, United States.
Jakub TolarStem Cell Institute, University of Minnesota, Minnesota, United States.ORCID http://orcid.org/0000-0002-0957-4380
Anja-Katrin BielinskyDepartment of Biochemistry, Molecular Biology, and Biophysics, The University of Minnesota, Minneapolis, United States.ORCID https://orcid.org/0000-0003-1783-619X
Jeremy E PurvisDepartment of Genetics, The University of North Carolina, Chapel Hill, United States.ORCID http://orcid.org/0000-0002-6963-0524
Jeanette Gowen CookDepartment of Biochemistry and Biophysics, The University of North Carolina, Chapel Hill, United States.ORCID https://orcid.org/0000-0003-0849-7405

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
TRAINING GRANT IN MICROBIOLOGY/CANCER RESEARCHT32CA009138 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Scott M. Dehm · 1985 to 2026
$11.3M
TRAINING IN HEMOGLOBIN &CELL MEMBRANE RESEARCHT32HL007062 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller, Gregory M Vercellotti · 1985 to 2026
$10.3M
Understanding the biological function of Mcm10 in yeastR01GM074917 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BIELINSKY, ANJA-KATRIN · 2005 to 2019
$3.7M
Replication Licensing and the Cell CycleR01GM083024 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN · 2009 to 2020
$2.9M
Post-Translational Regulation of DNA Replication Origin Licensing in Human CellsR01GM102413 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN · 2013 to 2021
$2.5M
Controlling Stem Cell Fate through Computational ModelingDP2HD091800 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PURVIS, JEREMY · 2016 to 2018
$2.3M
NCI NIH HHS P30 CA016086NCI NIH HHS P30 CA077598NCI NIH HHS T32 CA009138NHLBI NIH HHS T32 HL007062NICHD NIH HHS DP2 HD091800NIGMS NIH HHS R01 GM074917NIGMS NIH HHS R01 GM083024NIGMS NIH HHS R01 GM102413
6 · The paper itself

Abstract

Complete and robust human genome duplication requires loading minichromosome maintenance (MCM) helicase complexes at many DNA replication origins, an essential process termed origin licensing. Licensing is restricted to G1 phase of the cell cycle, but G1 length varies widely among cell types. Using quantitative single-cell analyses, we found that pluripotent stem cells with naturally short G1 phases load MCM much faster than their isogenic differentiated counterparts with long G1 phases. During the earliest stages of differentiation toward all lineages, MCM loading slows concurrently with G1 lengthening, revealing developmental control of MCM loading. In contrast, ectopic Cyclin E overproduction uncouples short G1 from fast MCM loading. Rapid licensing in stem cells is caused by accumulation of the MCM loading protein, Cdt1. Prematurely slowing MCM loading in pluripotent cells not only lengthens G1 but also accelerates differentiation. Thus, rapid origin licensing is an intrinsic characteristic of stem cells that contributes to pluripotency maintenance.

Indexed as

Cell CycleDNA ReplicationReplication OriginCell Cycle ProteinsCells, CulturedHumansPluripotent Stem CellsSingle-Cell AnalysisTime FactorsCDT1 protein, humanCell Cycle ProteinsCdt1cell cyclechromosomesdifferentiationG1geneshumanMCMsingle cell analysis

Identifiers

PMID29148972
PMCPMC5720591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.